What You Should Know:
– OncoHost, a company pioneering personalized medicine approaches for better patient outcomes, announced a collaborative research study with Dana-Farber Cancer Institute, a leading cancer treatment and research center.
– The project aims…
Continue Reading
By Shania Kennedy
June 03, 2024 – An AI tool developed by Mass General Brigham researchers has revealed that changes in muscle mass and fat quality over the course of immunotherapy are associated with poorer outcomes…
Continue Reading
NHS England has slashed investment in its flagship NHS AI Lab from a promised £250 million to just £139m, as it cuts back on national investment in NHS digitisation, Digital Health News has learned.The…
Continue Reading
By Shania Kennedy
May 31, 2024 – A magnetic resonance imaging (MRI)-based machine learning approach developed by researchers at UT Southwestern Medical Center could improve the detection of breast cancer metastasis and reduce the need for…
Continue Reading
by Owen Hughes Six imaging networks in England have selected global health tech firm Annalise.ai as their preferred provider to support early lung cancer diagnosis through NHS England’s AI Diagnostic Fund (AIDF).The £21 million fund,…
Continue Reading
What You Should Know:
– Color Health, a leader in comprehensive cancer care, announced today that it is partnering with SkinIO and Bexa to integrate their innovative solutions for skin and breast cancer screening into…
Continue Reading
What You Should Know:
– PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights.
– …
Continue Reading
Molecular classification, particularly microsatellite instability-high (MSI-H), has gained attention for immunotherapy in endometrial cancer (EC). MSI-H is associated with DNA mismatch repair defects and is a crucial treatment predictor. The NCCN guidelines recommend pembrolizumab…
Continue Reading
What You Should Know:
– A collaborative effort between COTA, PreciseDx, and Baptist Health South Florida seeks to revolutionize breast cancer recurrence risk assessment with the PreciseBreast™ (PDxBr) test. This AI-powered tool holds promise for…
Continue Reading
By 2030, the healthcare artificial intelligence market is expected to be worth almost $188 billion.The Institute of Electrical and Electronic Engineers, the world’s largest nonprofit technical organization dedicated to the advancement of technology for…
Continue Reading
